Medical Research
(H12)
IRS Verified
DX Registered
990 on File
ANN ARBOR ACTIVE AGAINST ALS
Financial strength (30%)
69/100
Reliability (20%)
50/100
Effectiveness (25%)
53/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$162K
Total Revenue
$79K
Total Expenses
$221K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
63.5%
Fundraising Efficiency
82.6%
Operating Reserve
33.70x
Liability-to-Asset
0.3%
Revenue Diversification
95.9%
Compared with Peers
FY 2023
Compared with 1,152 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
63.5% | 80.3% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
82.6% | 39.4% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
33.7 mo | 37.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.9% | 100.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
135.8% | -1.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.0% | -3.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
51.6% | 12.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $162K | $79K | $221K | 63.5% | — |
| 2022 | $69K | $74K | $137K | — | — |
| 2021 | $115K | $11K | N/A | — | 1 |
| 2018 | $215K | $100K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.